Translation Accelerator Core

Translation Accelerator Core

Goal & Research Areas

The Translational core will provide advice across all aspects of therapeutic development from target validation to commercialization; the core will also connect researchers to the appropriate advisors and facilities as appropriate to their projects.

Core Leader & Team

Kevin Grimes

Kevin Grimes

Learn More Learn More
Mark Smith

Mark Smith

Learn More Learn More
Jianwei Che

Jianwei Che

Learn More Learn More
Nathaneal Gray

Nathanael S. Gray

Learn More Learn More
Chaitan Khosla

Chaitan Khosla

Learn More Learn More

Hot Topic

Jeffrey Glenn receives $69 million to start antiviral drug-discovery center at Stanford

Jeffrey Glenn receives $69 million to start antiviral drug-discovery center at Stanford

The National Institute for Allergy and Infectious Diseases has awarded Jeffrey Glenn, MD, PhD, professor of hepatology and gastroenterology and of microbiology and immunology, $69 million...

Read More Learn More
Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial

Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial

A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.

Read More Learn More
Antiviral Program for Pandemics

Antiviral Program for Pandemics

The Antiviral Program for Pandemics (APP) aims to develop safe and effective antivirals to combat SARS-CoV-2, the virus that causes COVID-19, as well as to build sustainable platforms for targeted drug discovery and development of a robust pipeline of antivirals against viruses with pandemic potential.

Read More Learn More